[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$vrdn](/topic/$vrdn)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vrdn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vrdn/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-09-22  

**Most Supportive Themes**
- **Partnership and Breakthrough Therapy Designation:** (40%) Viridian Therapeutics' partnership with Kissei Pharma and the Breakthrough Therapy Designation for veligrotug are key positive developments.
- **Financial Health and Upcoming Launch:** (30%) The company's strong cash position and the planned 2026 US launch of veligrotug are viewed favorably.
  
**Most Critical Themes**
- **Declining Engagement and Mentions:** (15%)  The decrease in engagements, mentions, and creators over the past month suggests a cooling of social interest.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
| Reddit  | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |